300289 Stock Overview
Engages in the research and development, manufacture, and sale of in vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Beijing Leadman Biochemistry Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.27 |
| 52 Week High | CN¥6.74 |
| 52 Week Low | CN¥3.45 |
| Beta | -0.035 |
| 11 Month Change | 14.17% |
| 3 Month Change | -9.34% |
| 1 Year Change | -25.87% |
| 33 Year Change | -41.27% |
| 5 Year Change | -22.36% |
| Change since IPO | -35.34% |
Recent News & Updates
Shareholder Returns
| 300289 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 7.3% | 0.03% | -0.3% |
| 1Y | -25.9% | -20.4% | -18.1% |
Return vs Industry: 300289 underperformed the CN Biotechs industry which returned -20.4% over the past year.
Return vs Market: 300289 underperformed the CN Market which returned -18.1% over the past year.
Price Volatility
| 300289 volatility | |
|---|---|
| 300289 Average Weekly Movement | 5.7% |
| Biotechs Industry Average Movement | 5.6% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300289 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300289's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 538 | n/a | www.leadmanbio.com |
Beijing Leadman Biochemistry Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China. The company’s biochemical raw materials include enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications.
Beijing Leadman Biochemistry Co.,Ltd. Fundamentals Summary
| 300289 fundamental statistics | |
|---|---|
| Market cap | CN¥2.32b |
| Earnings (TTM) | -CN¥544.55k |
| Revenue (TTM) | CN¥422.96m |
5.5x
P/S Ratio-4,266x
P/E RatioIs 300289 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300289 income statement (TTM) | |
|---|---|
| Revenue | CN¥422.96m |
| Cost of Revenue | CN¥180.97m |
| Gross Profit | CN¥241.98m |
| Other Expenses | CN¥242.53m |
| Earnings | -CN¥544.55k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.001 |
| Gross Margin | 57.21% |
| Net Profit Margin | -0.13% |
| Debt/Equity Ratio | 0.2% |
How did 300289 perform over the long term?
See historical performance and comparison